GlassScriptPhysician profile
Bradley Castellano
NPI 1922079151
$7,320.74
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $2,403 · 2021: $141 · 2022: $3,594 · 2023: $34.88 · 2024: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $799 · Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $798.99 |
| Food and Beverage | $193.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,002.98 | 2020-2022 | |
| Curonix LLC | $957.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paragon 28, INC. | $599.58 | 2022 | |
| Mvp Orthopedics INC | $216.64 | 2022 | |
| Zimmer Biomet Holdings, INC. | $123.59 | 2019 | |
| Pacira Therapeutics, INC. | $120.71 | 2019-2021 | |
| Ethicon US, LLC | $106.89 | 2020 | |
| Medtronic, INC. | $92.64 | 2021 | |
| Fidia Pharma USA INC. | $30.63 | 2019-2021 | |
| Orthofix Medical, INC. | $21.58 | 2023 | Physio-Stim |
| Horizon Therapeutics Plc | $17.47 | 2021 | |
| Radius Health, INC. | $17.13 | 2022 | |
| Avanos Medical | $13.30 | 2023 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Castellano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.